NRGN and Alzheimer disease: Similar to GAP-43, Ng is depleted from the brain tissue in AD, but its levels become elevated in the CSF, reflecting damage to and degeneration of postsynaptic structures (Portelius et al., 2015; Casaletto et al., 2017).